PredxBio
Pittsburgh
About PredxBio
PredxBio is a computational pathology company that develops AI tools to analyze whole slide image pathology samples based on spatial analytics. The company helps clinicians and researchers accelerate drug discovery, optimize clinical trials, advance companion diagnostics, personalize therapeutic options, and improve clinical workflows. Its AI-based tool automatically recognizes and classifies regions of interest (ROIs) in H&E-stained and immunohistochemistry slides to help pathologists and biopharma companies use personalized spatial intelligence to make clinical decisions and make therapeutic strategies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.1M
- Funding stage: Seed
- Last round: Seed (Aug 2023)
- Website: predxbio.com
- Phone: [email protected]
Industries & Categories
Analytics, Artificial Intelligence (AI), Biotechnology, Clinical Trials, Medical
Social Profiles
Canonical: https://fsome.com/organization/predxbio-67966 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.